#9,751 by institutional money · Stock
Cocrystal Pharma, Inc. (COCP)
Institutional ownership from Q3 2026 Form 13F filings
$0.97
+1.04% today
Market closed. Prices as of Nov 20, 6:11 AM ET
- 13F holders
- 24 (−1)
- Held by 13F filers, live
- $1.1M
- Shares held
- 1,101,467
- Share of stock outstanding
- 5.7%
- Net buying in Q3 2026
- −$10K
- New positions / sold out
- 4 / 5
Largest holders
24 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 358,228 | $347K | <0.1% | Unchanged |
| Renaissance Technologies LLC | 174,998 | $170K | <0.1% | Reduced −3% |
| Two Sigma Investments, LP | 142,460 | $138K | <0.1% | Reduced −19% |
| Geode Capital Management, LLC | 124,446 | $121K | <0.1% | Added +63% |
| Vanguard Fiduciary Trust Co | 81,559 | $79K | <0.1% | Added +240% |
| BlackRock, Inc. | 73,746 | $72K | <0.1% | Unchanged |
| Citadel Advisors LLC Ken Griffin | 42,669 | $41K | <0.1% | Reduced −5% |
| Neuberger Berman Group LLC | 31,886 | $31K | <0.1% | Unchanged |
| State Street Corp | 20,543 | $20K | <0.1% | Unchanged |
| Parallel Advisors, LLC | 12,569 | $12K | <0.1% | Unchanged |
| Northern Trust Corp | 11,921 | $12K | <0.1% | Unchanged |
| XTX Topco Ltd | 11,176 | $11K | <0.1% | Reduced −62% |
| Tower Research Capital LLC (TRC) | 5,457 | $5K | <0.1% | Added +37% |
| Wells Fargo & Company/mn | 5,417 | $5K | <0.1% | Reduced −13% |
| Nuveen, LLC | 1,909 | $2K | <0.1% | New |
| Morgan Stanley | 913 | $886 | <0.1% | Added +5% |
| Northwestern Mutual Wealth Management Co | 817 | $792 | <0.1% | Unchanged |
| Clean Yield Group | 418 | $405 | <0.1% | Unchanged |
| UBS Group AG | 177 | $172 | <0.1% | Reduced −96% |
| Nvwm, LLC | 84 | $81 | <0.1% | Unchanged |
| SBI Securities Co., Ltd. | 33 | $32 | <0.1% | Unchanged |
| JPMORGAN Chase & Co | 27 | $26 | <0.1% | New |
| IFP Advisors, Inc | 13 | $13 | <0.1% | New |
| Citigroup Inc | 1 | $1 | <0.1% | New |